1. F110. SYMPTOMATIC REMISSION WITH PALIPERIDONE PALMITATE 3-MONTHLY FORMULATION IN SCHIZOPHRENIA PATIENTS IN A CLINICAL PRACTICE SETTING. (9th April 2019) Authors: Garcia-Portilla, M P; Llorca, P M; Maina, G; Bozikas, V P; Devrimci-Ozguven, H; Kim, S W; Bergmans, P; Usankova, I; Cherubin, P; Najarian, Dean; Pungor, K Journal: Schizophrenia bulletin Issue: Volume 45(2019)Supplement 2 Page Start: S295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of localisation of deep brain stimulation electrodes on motor and neurobehavioural outcomes in Parkinson's disease. Issue 7 (21st August 2015) Authors: de Chazeron, I; Pereira, B; Chereau-Boudet, I; Durif, F; Lemaire, J J; Brousse, G; Ulla, M; Derost, P; Debilly, B; Llorca, P M Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 87:Issue 7(2016) Page Start: 758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗